| Primary |
| Induction Of Anaesthesia |
28.3% |
| Drug Use For Unknown Indication |
8.3% |
| Endotracheal Intubation |
8.3% |
| Anaesthesia |
6.7% |
| Maintenance Of Anaesthesia |
6.7% |
| Sedative Therapy |
6.7% |
| Status Epilepticus |
6.7% |
| Intracranial Pressure Increased |
5.0% |
| Coma |
3.3% |
| Convulsion |
3.3% |
| Convulsion Prophylaxis |
3.3% |
| Electroconvulsive Therapy |
3.3% |
| Epilepsy |
3.3% |
| Pneumonia |
3.3% |
| General Anaesthesia |
1.7% |
| Pain |
1.7% |
|
| Drug Ineffective |
10.3% |
| Ileus |
6.9% |
| Pharmaceutical Product Complaint |
6.9% |
| Pulmonary Oedema |
6.9% |
| Rebound Effect |
6.9% |
| Tachycardia |
6.9% |
| Unwanted Awareness During Anaesthesia |
6.9% |
| Wrong Drug Administered |
6.9% |
| Bradycardia |
3.4% |
| Erythema |
3.4% |
| False Negative Laboratory Result |
3.4% |
| Haemodynamic Instability |
3.4% |
| Neutropenia |
3.4% |
| No Therapeutic Response |
3.4% |
| Oxygen Saturation Decreased |
3.4% |
| Procedural Complication |
3.4% |
| Procedural Pain |
3.4% |
| Pulse Absent |
3.4% |
| Rash |
3.4% |
| Spastic Paralysis |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.0% |
| Sedation |
9.5% |
| Epilepsy |
8.2% |
| Induction Of Anaesthesia |
7.4% |
| Surgery |
7.1% |
| Status Epilepticus |
6.9% |
| Head Injury |
6.3% |
| Product Used For Unknown Indication |
5.8% |
| Anaesthesia |
3.2% |
| Analgesia |
3.2% |
| Pain |
2.9% |
| Convulsion |
2.4% |
| Escherichia Infection |
2.4% |
| Escherichia Bacteraemia |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Sjogren's Syndrome |
2.1% |
| General Anaesthesia |
1.6% |
| Induction Of Anesthesia |
1.6% |
| Oral Surgery |
1.6% |
| Sedative Therapy |
1.6% |
|
| Mixed Liver Injury |
23.5% |
| Septic Shock |
7.8% |
| Tachycardia |
7.8% |
| Pancreatitis Acute |
5.9% |
| Status Epilepticus |
5.9% |
| Swelling Face |
5.9% |
| Torsade De Pointes |
5.9% |
| Agranulocytosis |
3.9% |
| Anaphylactic Reaction |
3.9% |
| Dermatitis Exfoliative |
3.9% |
| Hypoxia |
3.9% |
| Maternal Exposure During Pregnancy |
3.9% |
| Swollen Tongue |
3.9% |
| Anaphylactic Shock |
2.0% |
| Bradycardia |
2.0% |
| Cardiogenic Shock |
2.0% |
| Confusional State |
2.0% |
| Developmental Delay |
2.0% |
| Fatigue |
2.0% |
| Histiocytosis Haematophagic |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
51.6% |
| Drug Use For Unknown Indication |
8.5% |
| Anaesthesia |
6.5% |
| Coronary Artery Bypass |
5.6% |
| Catheterisation Cardiac |
3.8% |
| Status Epilepticus |
2.9% |
| General Anaesthesia |
2.6% |
| Premedication |
2.1% |
| Encephalitis Herpes |
1.8% |
| Pneumonia |
1.8% |
| Sternotomy |
1.8% |
| Aortic Valve Replacement |
1.5% |
| Atrial Fibrillation |
1.5% |
| Sedation |
1.5% |
| Contraception |
1.2% |
| Enteritis Infectious |
1.2% |
| Hypertension |
1.2% |
| Nodular (Follicular) Lymphoma |
1.2% |
| Preoperative Care |
1.2% |
| Cardiopulmonary Bypass |
0.9% |
|
| Tachycardia |
13.3% |
| Septic Shock |
8.9% |
| Torsade De Pointes |
8.9% |
| Anhedonia |
6.7% |
| Bradycardia |
6.7% |
| Injury |
6.7% |
| Pain |
6.7% |
| Toxic Skin Eruption |
6.7% |
| Anxiety |
4.4% |
| Renal Injury |
4.4% |
| Stress |
4.4% |
| Urine Output Decreased |
4.4% |
| Acute Generalised Exanthematous Pustulosis |
2.2% |
| Anaemia |
2.2% |
| Cardiac Arrest |
2.2% |
| Cardiac Disorder |
2.2% |
| Death |
2.2% |
| Depression |
2.2% |
| Drug Dose Omission |
2.2% |
| Drug Ineffective |
2.2% |
|
